Nandakumar Narayanan
Clinical trials sponsored by Nandakumar Narayanan, explained in plain language.
-
Can a blood pressure drug re-energize Parkinson's patients?
Disease control Not yet recruitingThis study tests whether terazosin, a drug currently used for high blood pressure, can improve energy metabolism in people with Parkinson's disease. Researchers will measure changes in a key energy molecule (ATP) in the blood of 120 participants over 6 weeks and 1.5 years. The go…
Phase: PHASE2 • Sponsor: Nandakumar Narayanan • Aim: Disease control
Last updated May 26, 2026 09:24 UTC
-
Old drug, new hope: could terazosin energize Parkinson's brains?
Disease control Not yet recruitingThis study tests whether terazosin, a common blood pressure medicine, can increase energy production in brain cells of people with early Parkinson's disease. About 100 participants will receive either terazosin or a placebo for 6 months. Researchers will measure energy levels in …
Phase: PHASE1, PHASE2 • Sponsor: Nandakumar Narayanan • Aim: Disease control
Last updated May 26, 2026 09:22 UTC